Pain relief, pharmacology, and the importance of medical supervision
Pain is one of the most universal of human experiences — yet it remains, in many cases, one of the most underestimated. When pain is moderate to severe and persistent, finding a form of relief that is both effective and well-tolerated becomes a clinical priority. Tramadol occupies a distinctive position in this landscape: a medication with a dual mechanism of action that sets it apart from conventional opioids, and one whose proper use requires both medical insight and considered supervision.
This article provides a clear and balanced overview of tramadol — what it is, how it works, the side effects to be aware of, and the regulatory framework that governs access to it in Thailand. Readers considering whether tramadol may be appropriate for their circumstances are encouraged to explore these pages as a starting point, and to follow up with a qualified clinician for a personalised assessment.
What Is Tramadol?
Tramadol is a centrally acting analgesic — that is, a pain-relieving medication that works primarily within the brain and spinal cord rather than at the site of injury. It was first synthesised in Germany in the 1970s and has since become one of the most widely prescribed pain medications globally, particularly for conditions involving moderate to moderately severe pain that do not respond adequately to non-opioid treatments such as paracetamol or non-steroidal anti-inflammatory drugs (NSAIDs, a class of drugs that includes ibuprofen and naproxen).
Tramadol is available in several formulations, including immediate-release oral tablets, extended-release tablets designed for around-the-clock pain management, and injectable preparations used in clinical settings. The choice of formulation is determined by the nature and duration of the pain being treated.
How Tramadol Works
What distinguishes tramadol from most other opioid analgesics is its dual mechanism of action — it operates via two separate but complementary pathways simultaneously.
The first is opioid receptor binding. Tramadol acts as a weak agonist at the mu-opioid receptor — the primary target of morphine and codeine — where it reduces the transmission of pain signals through the central nervous system. The opioid activity of tramadol is relatively modest compared with stronger opioids, which contributes to its generally lower risk profile when used appropriately.
The second mechanism involves monoamine reuptake inhibition. Tramadol inhibits the reuptake of serotonin and noradrenaline — two neurotransmitters involved in the body’s natural pain-modulating pathways. By increasing the availability of these neurotransmitters at nerve synapses, tramadol enhances descending pain inhibition: the process by which the brain itself suppresses incoming pain signals. It is this dual action that accounts for both tramadol’s distinct analgesic profile and some of its more nuanced side-effect considerations.
It is worth noting that tramadol is a prodrug in part — meaning that a proportion of its analgesic activity depends on its metabolic conversion in the liver to an active compound called O-desmethyltramadol. This metabolic step is governed by the enzyme CYP2D6, and individuals who are genetically slow metabolisers of this enzyme may experience reduced efficacy, while rapid metabolisers may be at greater risk of adverse effects at standard doses. This variability underscores the importance of individualised medical assessment.
Get in touch with Blooming Clinic to inquire about our services. (Bangkok Branch)
Therapeutic Applications
Tramadol is indicated for the management of moderate to moderately severe pain across a range of clinical contexts. These include post-operative pain, musculoskeletal and neuropathic pain conditions, osteoarthritis, and certain forms of chronic pain that have not responded sufficiently to first-line analgesics. Evidence also supports its use in the management of painful diabetic neuropathy and in palliative contexts where quality of life is the primary concern.
Its relative opioid-sparing properties make tramadol a considered choice in settings where clinicians wish to provide meaningful analgesia whilst minimising the sedation and respiratory depression associated with more potent opioids. That said, tramadol is not appropriate for all patients, and a careful assessment of the individual’s medical history, concurrent medications, and metabolic profile is essential before commencement.
Side Effects and Safety Considerations
As with any pharmacologically active agent, tramadol carries a recognised side-effect profile that patients and prescribers should be fully aware of. The most commonly reported effects include:
- Nausea, vomiting, and gastrointestinal discomfort — particularly when first commencing treatment
- Dizziness, drowsiness, and headache
- Dry mouth and constipation
- Sweating and mild changes in heart rate
Less commonly, tramadol may cause confusion, agitation, or mood disturbance, particularly in older adults or those receiving concurrent medications that affect serotonin levels. Of particular clinical significance is the risk of serotonin syndrome — a potentially serious condition caused by excess serotonergic activity — when tramadol is combined with certain antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) or monoamine oxidase inhibitors (MAOIs). For this reason, a thorough medication review is essential prior to prescribing.
Tramadol also carries a risk of dependence and tolerance with prolonged use, and should not be discontinued abruptly following extended treatment. Seizure risk is a further consideration, especially in individuals with a history of epilepsy or those taking medications that lower the seizure threshold. The medication is contraindicated in pregnancy, in those with severe renal or hepatic impairment, and in children under the age of twelve.
These considerations are not raised to alarm, but to illustrate clearly why tramadol requires proper medical oversight. When prescribed and monitored appropriately, it can be a well-tolerated and genuinely helpful medication for the right patient.
Get in touch with Blooming Clinic to inquire about our services. (Bangkok Branch)
Legal Status in Thailand
Thailand maintains a carefully regulated framework governing access to psychotropic and opioid medications, and tramadol falls squarely within this framework. In 2016, tramadol was reclassified by the Thai Food and Drug Administration (FDA) as a Category 2 Psychotropic Substance under the Psychotropic Substances Act B.E. 2518. This reclassification reflected growing awareness of the potential for misuse and dependency, and brought Thailand’s regulatory stance into closer alignment with international best practice.
The practical consequence of this classification is straightforward: tramadol is a prescription-only medication in Thailand. It cannot be purchased over the counter at a pharmacy without a valid prescription from a licensed medical practitioner. Possession of tramadol without a lawful prescription, or its sale without proper authorisation, constitutes a criminal offence under Thai law and carries significant penalties.
This regulatory framework serves an important purpose. It ensures that individuals who use tramadol do so under appropriate medical supervision, with a full assessment of their clinical suitability, ongoing monitoring, and access to professional guidance should any adverse effects occur. For residents and visitors in Thailand seeking pain relief, understanding this framework is essential — both for legal compliance and for personal safety.
Individuals who require tramadol for legitimate medical purposes are advised to seek a formal consultation with a qualified clinician who can assess their suitability, issue a lawful prescription, and provide the clinical oversight that safe use demands.
Key Facts at a Glance
| Tramadol at a Glance | |
| Drug class | Centrally acting analgesic (atypical opioid) |
| Primary use | Moderate to moderately severe acute and chronic pain |
| Mechanism | Mu-opioid receptor agonist; serotonin and noradrenaline reuptake inhibitor |
| Onset of action | Approximately 30–60 minutes (oral immediate-release) |
| Common formulations | Oral tablets (immediate- and extended-release); injection |
| Legal status (TH) | Prescription-only; Category 2 Psychotropic Substance |
| Prescription req. | Required — not available over the counter at pharmacies |
| Prescriber needed | Qualified medical practitioner |
The above is intended as a quick reference only. All clinical decisions should be made in consultation with a qualified medical practitioner.
Frequently Asked Questions
Is tramadol an opioid?
Tramadol is technically classified as an atypical opioid. It does act on opioid receptors, but its overall mechanism differs from conventional opioids such as morphine or codeine due to its additional effects on serotonin and noradrenaline. This dual action gives it a somewhat distinct risk and efficacy profile.
How does tramadol differ from codeine or ibuprofen?
Ibuprofen is a non-steroidal anti-inflammatory drug that acts peripherally at the site of inflammation and pain. Codeine is a traditional opioid that must be converted to morphine in the body to exert most of its analgesic effect. Tramadol combines a mild opioid action with monoamine reuptake inhibition, making it suitable for types of pain that may not respond well to either anti-inflammatories or standard opioids alone.
Can I become dependent on tramadol?
Yes — dependence is a recognised risk with regular, prolonged use. For this reason, tramadol is typically prescribed for the shortest effective duration, and any decision to discontinue should be made gradually under medical supervision to avoid withdrawal symptoms. Your prescribing clinician will advise accordingly.
Can tramadol be used alongside antidepressants?
This requires careful consideration. When combined with certain antidepressants — particularly SSRIs, SNRIs, or MAOIs — tramadol may increase the risk of serotonin syndrome, a condition requiring prompt medical attention. Always inform your clinician of all medications and supplements you are taking before commencing tramadol.
Why can’t I simply purchase tramadol at a pharmacy in Thailand?
Since its reclassification as a Category 2 Psychotropic Substance in 2016, tramadol is a prescription-only medication in Thailand. This means a valid prescription from a licensed medical practitioner is required for any lawful purchase. The regulation exists to protect patients and ensure that those using tramadol do so under appropriate medical oversight.
How do I access tramadol legally and safely in Thailand?
The appropriate route is through a consultation with a qualified medical practitioner, who can conduct a thorough assessment of your pain condition, medical history, and medication profile. If tramadol is clinically indicated, the practitioner will issue a prescription and provide the ongoing supervision that responsible use requires. Clinics offering medically supervised pain management are well-placed to guide patients through this process.
Are there people for whom tramadol is not suitable?
Yes. Tramadol is contraindicated in pregnancy, in children under the age of twelve, in individuals with severe kidney or liver impairment, and in those with a history of seizure disorders. It is also unsuitable for individuals taking certain classes of antidepressant. A comprehensive consultation with a clinician will identify whether any of these factors apply.
Tramadol is a well-established analgesic with a distinctive pharmacological profile that makes it a valuable option for appropriately selected patients experiencing moderate to severe pain. Its dual mechanism, when combined with careful clinical assessment and monitoring, can offer meaningful relief with a manageable safety profile. However, like all medications of its class, tramadol demands respect — for its efficacy, its risk profile, and the regulatory framework that governs its use.
In Thailand, legal and safe access to tramadol begins with a consultation with a licensed clinician. An experienced practitioner will assess your individual circumstances, confirm whether tramadol is appropriate, issue a lawful prescription, and provide the continuity of care that responsible pain management requires. If you are living with pain that has proved difficult to manage, a consultation with our clinical team offers a thorough, confidential, and considered starting point.
Get in touch with Blooming Clinic to inquire about our services. (Bangkok Branch)
References
1. Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879–923.
2. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol. J Pharmacol Exp Ther. 1992;260(1):275–285.
3. Dayer P, Desmeules J, Collart L. Pharmacology of tramadol. Drugs. 1997;53(Suppl 2):18–24.
4. Scott LJ, Perry CM. Tramadol: a review of its use in perioperative pain. Drugs. 2000;60(1):139–176.
5. Miotto K, Cho AK, Khalil MA, Blanco K, Sasaki JD, Rawson R. Trends in tramadol: pharmacology, metabolism, and misuse. Anesth Analg. 2017;124(1):44–51.
6. Food and Drug Administration Thailand. Notification re: Classification of Tramadol as Category 2 Psychotropic Substance. Bangkok: Thai FDA; 2016.
7. World Health Organization. WHO Expert Committee on Drug Dependence: Critical Review of Tramadol. Geneva: WHO; 2021.
8. Subrungruang I, Tangcharoensathien V. Regulation of tramadol in Thailand: context, evidence and policy response. Drug Alcohol Rev. 2019;38(4):432–438.
9. Tashiro A, Bereiter DA. Serotonin syndrome associated with tramadol use: a systematic review. Pharmacotherapy. 2018;38(7):765–774.
10. Senay EC, Adams EH, Geller A, et al. Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur. Drug Alcohol Depend. 2003;69(3):233–241.